E. González-Billalabeitia

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

D. Amadori, D. Dearnaley, M. Climent, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.

C. Bokemeyer, T. Hermanns, C. Fankhauser, 2020, European urology focus.